Next Article in Journal
Informing Canada’s Cancer Drug Funding Decisions with Scientific Evidence and Patient Perspectives: The Pan-Canadian Oncology Drug Review
Previous Article in Journal
What is the Burden of Axillary Disease after Neoadjuvant Therapy in Women with Locally Advanced Breast Cancer?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 20
Issue 2
10.3747/co.20.1351
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

New Chart Review Data Validate Administrative Data–Based Indicator for Guideline-Recommended Treatment of Locally Advanced Non-Small-Cell Lung Cancer and Shed Light on Reasons for Non-Referral and Non-Treatment

by
J. Klein–Geltink
1,*,
T. Forte
1,*,
R. Rahal
1,
G. Darling
2,
W. Cheung
3,
R. Alvi
4,
G. Noonan
5,
C. Russell
6,
K. Vriends
7,
J. Niu
1,
G. Lockwood
1,8 and
H. Bryant
1,9
1
Canadian Partnership Against Cancer, Toronto, ON, Canada
2
Toronto General Hospital, University Health Network, Toronto, ON, Canada
3
British Columbia Cancer Agency, Vancouver, BC, Canada
4
Saskatchewan Cancer Agency, Saskatoon, SK, Canada
5
CancerCare Manitoba, Winnipeg, MB, Canada
6
Alberta Health Services, Edmonton, AB, Canada
7
PEI Cancer Treatment Centre, Charlottetown, PE, Canada
8
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
9
Departments of Community Health Sciences and Oncology, University of Calgary, Calgary, AB, Canada
*
Authors to whom correspondence should be addressed.
Curr. Oncol. 2013, 20(2), 118-120; https://doi.org/10.3747/co.20.1351
Submission received: 2 January 2013 / Revised: 3 February 2013 / Accepted: 4 March 2013 / Published: 1 April 2013

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The 2012 Cancer System Performance Report is the 4th annual report on the Canadian cancer control system produced by the System Performance initiative at the Canadian Partnership Against Cancer, in collaboration with its provincial and national partners. [...]

Share and Cite

MDPI and ACS Style

Klein–Geltink, J.; Forte, T.; Rahal, R.; Darling, G.; Cheung, W.; Alvi, R.; Noonan, G.; Russell, C.; Vriends, K.; Niu, J.; et al. New Chart Review Data Validate Administrative Data–Based Indicator for Guideline-Recommended Treatment of Locally Advanced Non-Small-Cell Lung Cancer and Shed Light on Reasons for Non-Referral and Non-Treatment. Curr. Oncol. 2013, 20, 118-120. https://doi.org/10.3747/co.20.1351

AMA Style

Klein–Geltink J, Forte T, Rahal R, Darling G, Cheung W, Alvi R, Noonan G, Russell C, Vriends K, Niu J, et al. New Chart Review Data Validate Administrative Data–Based Indicator for Guideline-Recommended Treatment of Locally Advanced Non-Small-Cell Lung Cancer and Shed Light on Reasons for Non-Referral and Non-Treatment. Current Oncology. 2013; 20(2):118-120. https://doi.org/10.3747/co.20.1351

Chicago/Turabian Style

Klein–Geltink, J., T. Forte, R. Rahal, G. Darling, W. Cheung, R. Alvi, G. Noonan, C. Russell, K. Vriends, J. Niu, and et al. 2013. "New Chart Review Data Validate Administrative Data–Based Indicator for Guideline-Recommended Treatment of Locally Advanced Non-Small-Cell Lung Cancer and Shed Light on Reasons for Non-Referral and Non-Treatment" Current Oncology 20, no. 2: 118-120. https://doi.org/10.3747/co.20.1351

Article Metrics

Back to TopTop